Prof Charles Feldman

Charles Feldman is a South African academic clinician and researcher widely recognised for contributions to pulmonology and infectious diseases. Based at the University of the Witwatersrand and Charlotte Maxeke Johannesburg Academic Hospital, his work bridges clinical medicine, microbiology, and public health, with a strong focus on community-acquired pneumonia, antimicrobial resistance, and respiratory infections in high HIV-burden settings.

His publications highlight major themes including severe pneumonia, pneumococcal disease, non-tuberculous mycobacterial infections, and the intersection of smoking, chronic disease, and infection risk. Research explores pathogen resistance patterns, biofilm dynamics, vaccine impact on invasive pneumococcal disease, and stewardship challenges in chronic respiratory care, alongside critical care practices and end-of-life decision-making.

Feldman’s scholarship demonstrates leadership in large surveillance collaborations and clinically grounded investigations that inform vaccination policy and antimicrobial strategies in sub-Saharan Africa. His work has shaped understanding of respiratory disease epidemiology, vaccine benefits across age groups, and the complex overlap between cardiac and pulmonary illness, reinforcing his standing as a key voice in respiratory and infectious disease research.